← Leaderboards
Allan Y Chen
Marshall University
$826,100
Attributed
$826,100
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $200.5K · FY2007–11$250K$187.5K$125K$62.5K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$826,100 · 5
By mechanism
P20$826,100 · 5
Top collaborators
No co-investigators on record.
Most similar at Marshall University
Same institution · by research overlap
- Gary O. Rankin$41,685,974
- Donald Anthony Primerano$11,263,094
- Mark J Reasor$2,428,325
- Mary E Davis$2,475,910
- James Denvir$3,291,391
Others in their field
Top investigators on “Ovarian Neoplasm”
- David Heimbrook · Leidos Biomedical Research, Inc.$140,572,844
- Philip J Disaia · University Of California Irvine$112,550,334
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,727,040
- Lynn Briscoe · Leidos Biomedical Research, Inc.$26,195,254
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$25,723,601
- Robert C Bast · University Of Texas Md Anderson Can Ctr$24,692,917
Research focus
Ovarian NeoplasmMalignant Neoplasm Of OvaryTumor GrowthAntioxidantsSourceMediatingMolecularSignal PathwayResourcesProtective EffectCancer CellCell ProliferationColonAngiogenesisFlavonoidsFruits And VegetablesFundingApigeninGrantInsightLungUnited States National Institutes Of HealthComputer Retrieval Of Information On Scientific Projects DatabaseInstitution
Grant awards (5)
PI3K, AKT AND ERR-ALPHA PATHWAYS IN FLAVONOID-INHIBITING TUMORIGENESIS$144,326
P20 · FY2011 · RR · contact PI
PI3K, AKT AND ERR-ALPHA PATHWAYS IN FLAVONOID-INHIBITING TUMORIGENESIS$200,546
P20 · FY2010 · RR · contact PI
SIGNALING PATHWAYS IN APIGENIN-INHIBITING TUMOR GROWTH$166,860
P20 · FY2009 · RR · contact PI
SIGNALING PATHWAYS IN APIGENIN-INHIBITING TUMOR GROWTH$164,796
P20 · FY2008 · RR · contact PI
SIGNALING PATHWAYS IN APIGENIN-INHIBITING TUMOR GROWTH$149,572
P20 · FY2007 · RR · contact PI